949196-45-6

Basic information

• Product Name: 5-bromo-N-(cyclopropylmethyl)-3-nitropyridin-2-amine
• Synonyms: 5-bromo-N-(cyclopropylmethyl)-3-nitropyridin-2-amine
• CAS NO: 949196-45-6
• Molecular Weight: 272.101
• Mol File: 949196-45-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 5-bromo-N-(cyclopropylmethyl)-3-nitropyridin-2-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-bromo-N-(cyclopropylmethyl)-3-nitropyridin-2-amine(949196-45-6)
• EPA Substance Registry System: 5-bromo-N-(cyclopropylmethyl)-3-nitropyridin-2-amine(949196-45-6)

Safety Data

• Hazardous Substances Data: 949196-45-6(Hazardous Substances Data)

Upstream product

• 67443-38-3 5-bromo-2-chloro-3-nitropyridine 
• 2516-47-4 cyclopropanemethylamine 

Relevant articles and documents

SULFONYL BENZIMIDAZOLE DERIVATIVES

This invention relates to compounds of the formula (I): or a pharmaceutically acceptable salt thereof, wherein A, R1, R2 ,R3, R4, R5, m and n are each as described herein, and compositions containing such compounds, and the use of such compounds in the treatment of a condition mediated by CB2 receptor activity such as, but not limited to, inflammatory pain, nociceptive pain, neuropathic pain, fibromyalgia, chronic low back pain, visceral pain, acute cerebral ischemia, pain, chronic pain, acute pain, post herpetic neuralgia, neuropathies, neuralgia, diabetic neuropathy, HIV-related neuropathy, nerve injury, rheumatoid arthritic pain, osteoarthritic pain, back pain, cancer pain, dental pain, fibromyalgia, neuritis, sciatica, inflammation, neurodegenerative disease, cough, broncho constriction, irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), colitis, cerebrovascular ischemia, emesis such as cancer chemotherapy-induced emesis, rheumatoid arthritis, asthma, Crohn's disease, ulcerative colitis, asthma, dermatitis, seasonal allergic rhinitis, GERD, constipation, diarrhea, functional gastrointestinal disorders, irritable bowel syndrome, cutaneous T cell lymphoma, multiple sclerosis, osteoarthritis, psoriasis, systemic lupus erythematosus, diabetes, glaucoma, osteoporosis, glomerulonephritis, renal ischemia, nephritis, hepatitis, cerebral stroke, vasculitis, myocardial infarction, cerebral ischemia, reversible airway obstruction, adult respiratory disease syndrome, COPD, cryptogenic fibrosing alveolitis and bronchitis.